Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
尼洛替尼对帕金森病患者安全性、耐受性和潜在生物标志物的影响:一项 II 期随机临床试验
期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2019.4200
Pagan, Fernando L; Hebron, Michaeline L; Wilmarth, Barbara; Torres-Yaghi, Yasar; Lawler, Abigail; Mundel, Elizabeth E; Yusuf, Nadia; Starr, Nathan J; Anjum, Muhammad; Arellano, Joy; Howard, Helen H; Shi, Wangke; Mulki, Sanjana; Kurd-Misto, Tarick; Matar, Sara; Liu, Xiaoguang; Ahn, Jaeil; Moussa, Charbel